H.R. 768: Stop AIDS in Prison Act of 2015

Before you vote › Federal bills

H.R. 768: Stop AIDS in Prison Act of 2015

114th Congress · introduced 2015-02-05 · Crime and Law Enforcement · Latest: Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

federal

Save to my notebook What does this mean? Print

Official title

Stop AIDS in Prison Act of 2015

Plain summary

Stop AIDS in Prison Act of 2015 Directs the Bureau of Prisons to develop a comprehensive policy to provide HIV testing, treatment, and prevention for inmates in federal prisons and upon reentry into the community. Requires such policy to include provisions for: (1) testing of inmates upon intake and counseling; (2) HIV/AIDS prevention education; (3) HIV testing of prisoners annually upon request or upon exposure to HIV; (4) HIV testing of pregnant inmates; (5) comprehensive medical treatment of inmates who test positive for HIV and confidential counseling on managing their medical condition and preventing its transmission to other persons; (6) protection of confidentiality; (7) testing, counseling, and referral prior to reentry into the community; (8) allowing inmates the right to refuse routine HIV testing; (9) excluding as "routine" the testing of an inmate who may have transmitted HIV to any U.S. officer or employee or to any person lawfully present but not incarcerated in a correctional facility; and (10) timely notification of test results. Amends the federal criminal code to: (1) require HIV testing for all federal prison inmates upon intake regardless of length of sentence or risk factors, (2) allow inmates to decline testing prior to release from incarceration, and (3) make HIV testing part of the routine health screening conducted at intake. Requires the Bureau to report on: (1) testing, treatment, and prevention education programs for hepatitis and other diseases transmitted through sexual activity and intravenous drug use; and (2) the incidence among prison inmates of diseases transmitted through sexual activity and intravenous drug use.

Congressional Research Service summary (Introduced in House), quoted unchanged (nonpartisan). Read the source.

What a vote does

PSI Sci description of the legislative step (not an opinion).

The strongest published arguments

Alternatives

Needs sources: no published alternatives yet (for example a different bill, a law instead of an amendment, or keeping current law). We only show items backed by a published source. Suggest one.

How did my representative vote? · This bill's floor votes

Officials and money

Sponsor: Rep. Waters, Maxine [D-CA-43] · 35 cosponsors

Cost estimate: No cost estimate published yet.

Cosponsors on this site

Robert C. "Bobby" Scott (D-VA), Yvette D. Clarke (D-NY), Eleanor Holmes Norton (D-DC), Henry C. "Hank" Johnson, Jr. (D-GA), Jerrold Nadler (D-NY), Gwen Moore (D-WI), Janice D. Schakowsky (D-IL), Danny K. Davis (D-IL), Gregory W. Meeks (D-NY), Bonnie Watson Coleman (D-NJ), Nydia M. Velázquez (D-NY), André Carson (D-IN), Mike Quigley (D-IL), Donald S. Beyer, Jr. (D-VA), Frederica S. Wilson (D-FL), Judy Chu (D-CA), Hakeem S. Jeffries (D-NY), Marc A. Veasey (D-TX), Scott H. Peters (D-CA)

Sponsor's campaign money: Rep. Waters, Maxine [D-CA-43] reported raising $1.1 million (2025–2026). Details. Shown for context only; it does not mean any donor supported this bill.

No linked floor roll calls in our collected records yet. This does not mean the bill has never had a vote. Check the official bill history.

Sources

• Congressional Research Service summary (Introduced in House)
• Congress.gov
• Data: GovInfo BILLSTATUS bulk data (Library of Congress), BILLSTATUS-114hr768.xml <https://www.govinfo.gov/bulkdata/BILLSTATUS/114/hr>

Record fed-us-cong114-hr768 · catalog fed-us-congress-bills-cong114 · updated 2026-11-15 by psicol fed-bills-cong114